Over the past 12 months, 11 insiders at ARDELYX, INC. filed 64 open-market SEC Form 4 transactions on ARDX: 1 purchase worth $1.9M and 63 sales worth $4.8M. Insiders have been net sellers over this period. The most recent filing was on Jul 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 26 | Michael RaabPresident & CEO, Director | SELL | 41.7K | $5.06 | $211K |
| Jun 18, 26 | Laura A WilliamsChief Patient Officer | SELL | 81.9K | $5.99 | $490K |
| Jun 15, 26 | Michael RaabPresident & CEO | SELL | 41.7K | $5.67 | $236K |
| May 21, 26 | John E BishopSee Remarks | SELL | 2.3K | $6.27 | $14K |
| May 21, 26 | James Parker BradyChief Human Resources Officer | SELL | 1.8K | $6.27 | $12K |
| May 21, 26 | Eric Duane FosterChief Commercial Officer | SELL | 3.2K | $6.27 | $20K |
| May 21, 26 | Susan HohenleitnerChief Financial Officer | SELL | 1.5K | $6.27 | $9K |
| May 21, 26 | Mike KelliherChief Business Officer | SELL | 2.9K | $6.27 | $18K |
| May 21, 26 | Michael RaabPresident & CEO | SELL | 17.9K | $6.27 | $112K |
| May 21, 26 | Joseph James ReillySee Remarks | SELL | 2.7K | $6.27 | $17K |
| May 21, 26 | Laura A WilliamsChief Patient Officer | SELL | 2.2K | $6.27 | $14K |
| May 15, 26 | Michael RaabPresident & CEO | SELL | 41.7K | $6.28 | $262K |
| Apr 15, 26 | Michael RaabPresident & CEO | SELL | 41.7K | $6.29 | $262K |
| Mar 16, 26 | Michael RaabPresident & CEO | SELL | 41.7K | $5.84 | $243K |
| Feb 24, 26 | Michael RaabPresident & CEO | SELL | 41.7K | $6.26 | $261K |
| Feb 20, 26 | John E BishopSee Remarks | SELL | 2.8K | $5.87 | $16K |
| Feb 20, 26 | James Parker BradyChief Human Resources Officer | SELL | 2.2K | $5.87 | $13K |
| Feb 20, 26 | Eric Duane FosterChief Commercial Officer | SELL | 9.2K | $5.87 | $54K |
| Feb 20, 26 | Susan HohenleitnerChief Financial Officer | SELL | 1.8K | $5.87 | $10K |
| Feb 20, 26 | Mike KelliherSee Remarks | SELL | 8.4K | $5.87 | $50K |
| Feb 20, 26 | David M MottDirector | BUY | 333.3K | $5.84 | $1.9M |
| Feb 20, 26 | Michael RaabPresident & CEO | SELL | 40.4K | $5.87 | $237K |
| Feb 20, 26 | Joseph James ReillySee Remarks | SELL | 4.4K | $5.87 | $26K |
| Feb 20, 26 | Laura A WilliamsSee Remarks | SELL | 7.2K | $5.87 | $42K |
| Jan 8, 26 | Laura A WilliamsChief Patient Officer | SELL | 50.0K | $6.98 | $349K |
| Nov 21, 25 | Eric Duane FosterChief Commercial Officer | SELL | 5.8K | $5.54 | $32K |
| Nov 21, 25 | Elizabeth A GrammerSee Remarks | SELL | 6.0K | $5.54 | $33K |
| Nov 21, 25 | Mike KelliherSee Remarks | SELL | 5.6K | $5.54 | $31K |
| Nov 21, 25 | Michael RaabPresident & CEO | SELL | 46.9K | $5.54 | $260K |
| Nov 21, 25 | Joseph James ReillySee Remarks | SELL | 11.1K | $5.54 | $61K |
| Nov 21, 25 | Laura A WilliamsChief Patient Officer | SELL | 6.4K | $5.54 | $36K |
| Aug 26, 25 | Laura A WilliamsChief Patient Officer | SELL | 50.0K | $6.12 | $306K |
| Aug 21, 25 | Eric Duane FosterChief Commercial Officer | SELL | 15.3K | $5.93 | $91K |
| Aug 21, 25 | Elizabeth A GrammerSee Remarks | SELL | 5.8K | $5.93 | $35K |
| Aug 21, 25 | Mike KelliherChief Business Officer | SELL | 5.4K | $5.93 | $32K |
| Aug 21, 25 | Michael RaabPresident & CEO | SELL | 45.7K | $5.93 | $271K |
| Aug 21, 25 | Justin A RenzChief Financial Officer | SELL | 7.0K | $5.93 | $42K |
| Aug 21, 25 | Laura A WilliamsChief Patient Officer | SELL | 6.3K | $5.93 | $37K |
| Jun 16, 25 | David M MottDirector | BUY | 200.0K | $3.63 | $726K |
| Jun 9, 25 | David M MottDirector | BUY | 200.0K | $3.69 | $738K |
| May 20, 25 | Eric Duane FosterChief Commercial Officer | SELL | 2.5K | $4.08 | $10K |
| May 20, 25 | Elizabeth A GrammerSee Remarks | SELL | 6.0K | $4.08 | $24K |
| May 20, 25 | Mike KelliherSee Remarks | SELL | 14.5K | $4.08 | $59K |
| May 20, 25 | Michael RaabPresident & CEO | SELL | 46.8K | $4.08 | $191K |
| May 20, 25 | Justin A RenzChief Financial Officer | SELL | 7.2K | $4.08 | $29K |
| May 20, 25 | Laura A WilliamsChief Medical Officer | SELL | 6.4K | $4.08 | $26K |
| May 15, 25 | David M MottDirector | BUY | 100.0K | $3.29 | $329K |
| May 2, 25 | David M MottDirector | BUY | 381.4K | $4.22 | $1.6M |
| May 2, 25 | Michael RaabPresident & CEO | SELL | 41.7K | $4.25 | $177K |
| Apr 4, 25 | Michael RaabPresident & CEO | SELL | 41.7K | $4.59 | $191K |
Over the past 12 months, insiders at ARDELYX, INC. filed 1 open-market purchase worth $1.9M and 63 sales worth $4.8M on ARDX, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 15, 26.
The largest recent open-market ARDX insider purchase in our data was $1.9M by David M Mott, Director, filed on Feb 20, 26.
11 different insiders at ARDELYX, INC. filed open-market SEC Form 4 transactions on ARDX over the last 12 months.
InsiderTape plots every ARDX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ARDELYX, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →